MEA Anatomic Pathology Market

MEA Anatomic Pathology Market Size (2023 to 2028)

The Middle East & Africa Anatomic Pathology Market was worth USD 1.53 billion in 2023 and is estimated to be growing at a CAGR of 4.8% to reach USD 1.93 billion by 2028.

The increasing prevalence of cancer cases across the Middle East and Africa countries drives the growth of the anatomy pathology market in MEA during the forecast period. Cancer remains a major cause of death in the MEA region. Factors such as abnormal cell proliferation, hormonal changes, genetic predisposition, unhealthy diets and pollutant exposure primarily contribute to the incidence of cancer among the population of MEA countries. A survey in Egypt 2020 reported 61,160 breast cancer cases, 28,977 liver cancer cases, and 26,986 bladder cancer cases, among others. To combat cancer and reduce mortality rates, pathologists are researching advanced treatments. Anatomical pathology, a branch of pathology, plays a crucial role in tissue diagnosis of diseases. Anatomical pathologists possess extensive knowledge of various diseases' pathological and clinical aspects, aiding in disease diagnosis and treatment management. Anatomic pathology is vital in identifying and managing tumors, cancers, and other diseases, including kidney, liver, autoimmune, and infectious diseases. Market growth is driven by the demand for pathologists' examination of tissues removed during surgeries for diagnostic purposes.

The rising adoption of advanced technology in pathology instruments further propels the growth of the anatomy pathology market in the MEA. Digital pathology is a cutting-edge technology that utilizes virtual microscopy to share high-quality images electronically, enhancing the analysis process. Furthermore, the integration of advanced technologies like artificial intelligence and machine learning enables the creation of algorithms for medical image analysis to drive the MEA market growth. Researchers and manufacturers focus on developing microscopic devices and slides used in pathology studies. The growing investment by research organizations, government support, and favorable reimbursement policies further contribute to the growth of the MEA market.

The high cost of pathology devices and instruments is one of the factors hampering the growth of the anatomy pathology market in MEA. Factors such as a shortage of skilled professionals, limited awareness about pathology technologies and inadequate infrastructure facilities further impede market growth in the MEA region.

This research report on the MEA Anatomic Pathology Market has been segmented & sub-segmented into the following categories:

By Product: 

• Instruments
• Accessories

By End-User: 

• Diagnostics Lab
• Hospitals
• Physicians’ Office Lab

By Application: 

• Lymphoma
• Breast
• Lung
• Cervical
• Colorectal
• Prostate

By Country: 

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

The Middle East and Africa region is gaining popularity in the anatomic pathology market by establishing more pathology institutes and increased manufacturing facilities for portable pathology microscopic devices, enhancing tissue analysis convenience. UAE experiences market growth primarily due to the increasing number of pathology laboratories launched, supported by the government's stringent certification rules and skilled pathologists. Similarly, Saudi Arabia contributes to the market with ample pathology job opportunities and a rise in anatomic pathology programs. The presence of key players, ongoing mergers and acquisitions, and increased investment in infrastructure facilities further drive market growth in the region.

KEY MARKET PLAYERS:

This market is small in this region, with few developing players operating in the business. However, some of the major companies dominating the market in this region are MetaMed, JDW Pathology Home, and HPLAB Inc.